15.2 Million Vaccine Doses Arrive in Indonesia in 3 Batches
TEMPO.CO, Jakarta - The Indonesian government received 15.2 million doses of the AstraZeneca and Sinovac COVID-19 vaccines in three batches on Monday afternoon.
"There are two types of vaccine brands that have arrived: from AstraZeneca as many as 1,086 thousand doses and Sinovac as many as five million doses," Coordinating Minister for Human Development and Culture (PMK), Muhadjir Effendy, said while delivering a press statement that was virtually monitored here on Monday.
The 43rd and 44th batches of the vaccines from the two brands were received in the form of finished products, he informed.
Meanwhile, the 45th arrival batch of around 9.2 million vaccine doses was received from Sinovac in the form of raw materials, taking the number of vaccine doses received on Monday to 15.2 million.
"These vaccine arrivals are the arrival of the 43rd, 44th, 45th stages, and more arrivals will continue," he said.
The minister said the arrival of vaccines in the country is evidence that the government is continuing to work hard to secure COVID-19 vaccines and meet national vaccination needs.
"As of August 26, 2021, the achievement of the first dose of vaccination is 28.53 percent, while the second dose of vaccine is 16.02 percent," he added.
According to Effendy, the acceleration of vaccinations requires very close cooperation and the role of all elements of the nation. Therefore, it is crucial for all parties to take part in making the nation's vaccination program successful, he said.
Indonesia is facing the reality of coexisting with the COVID-19 pandemic, he remarked.
Therefore, all parties must continue to tighten cooperation and encourage the compliance of all elements of the nation in implementing the health protocols, the minister said.
He also invited people to visit vaccination locations without delay and refrain from only getting specific vaccine brands, saying all vaccines being used in the nation's vaccination program are beneficial for boosting immunity against COVID-19.